Search for content and authors
 

DESIGN AND SYNTHESIS OF NEW 7-PHENYLPIPERAZINYLALKYL AND 7-TETRAHYDROISOQUINOLINYLALKYL DERIVATIVES OF PURINE-2,6,8-TRIONE AS POTENTIAL SEROTONIN RECEPTOR AGENTS

Grażyna Chłoń-Rzepa 1Paweł Żmudzki 1Maciej Pawłowski 1Andrzej J. Bojarski 2Sijka Charakchieva-Minol 2Beata Duszyńska 2

1. Jagiellonian University, Collegium Medicum, Department of Pharmaceutical Chemistry, Medyczna 9, Kraków 30-688, Poland
2. Polish Academy of Sciences. Institute of Pharmacology, Smętna 12, Kraków 31-343, Poland

Abstract

It is known that pharmacophoric arylpiperazine fragment is well recognized by
5-HT1A, 5-HT2A, as well as 5-HT7 receptors. Although the terminal amide fragment significantly affects binding of 1-arylpiperazine derivatives with serotonin receptors, its role is not clear yet. In our earlier attempt to find new 5-HT1A/5-HT2A receptor ligands several series of arylpiperazinylalkyl theophylline derivatives have been synthesized and their affinities for 5-HT1A and 5-HT2A were determined [1-3]. The selected compounds were potent 5-HT1A receptor ligands [2]. In order to explain the influence of theophylline (purine-2,6-dione) moiety on serotonin receptors affinity, purine-2,6,8-trione analogues were obtained. Additionally the arylpiperazine fragment was modified by introduction of 1,2,3,4-tetrahydroisoquinoline.

gd2_1.gif

Previously obtained 1,3-dimethyl-7-(3-chloroalkyl)-8-methoxy-purine-2,6-dione in the reaction with appropriate piperazine derivatives and 1,2,3,4-tetrahydroisoquinoline yielded final products, which were isolated as a hydrochloride salts. The purity of the compounds were controlled by TLC, the structures were confirmed by spectral (1H-NMR, MS, UV), and C, H, N analyses.

The 7-{4-[4-(3-chlorophenyl)-piperazin-1-yl]-butyl}-1,3-dimethyl-7,9-dihydro-3H-purine-2,6,8-trione was preliminary evaluated for its affinity to 5-HT1A, 5-HT2A and 5-HT7 receptors. It was found that this compound was 5-HT2A receptor ligand (Ki = 63 nM) with moderate 5-HT1A (Ki = 263 nM), and low 5-HT7 (Ki = 1820 nM) receptor affinity.

References:

1. M. Pawłowski, G. Chłoń, et al.: Il Farmaco, 55, 461, 2000.

2. G. Chłoń, M. Pawłowski, et al.: Pol. J. Pharmacol., 53, 359, 2001.

3. P. Zajdel, A.J. Bojarski, H. Byrtus, G. Chłoń-Rzepa, et al.: Biomed. Chromatogr. 17, 312, 2003.

 

Legal notice
  • Legal notice:
 

Related papers

Presentation: Poster at V Multidyscyplinarna Konferencja Nauki o Leku, by Grażyna Chłoń-Rzepa
See On-line Journal of V Multidyscyplinarna Konferencja Nauki o Leku

Submitted: 2006-01-27 13:19
Revised:   2009-06-07 00:44